Jan 18, 2012
Cadwalader, Wickersham & Taft LLP, a leading counselor to global financial institutions and corporations, today announced that Christopher Cox, an accomplished transactional lawyer, has joined the firm’s Corporate Department as a partner. Cox, formerly a partner at Cahill Gordon & Reindel LLP, will reside in Cadwalader’s New York office.
“Chris’s decision to join Cadwalader reflects our commitment to attract top talent and provide the highest quality legal advice to companies navigating complicated terrain in a complex economic climate,” said W. Christopher White, Cadwalader Chairman. “We are very pleased to have him join the partnership, and believe our clients will be delighted to have access to his counsel.”
Cox has advised public and private companies, private equity firms and financial institutions in U.S. and cross-border mergers, acquisitions, dispositions, joint ventures, capital raising transactions and strategic investments, as well as a wide range of governance, compliance and other business-related matters. In particular, he has extensive experience in the pharmaceutical industry.
Cox has worked on a broad range of engagements for industry leaders such as Élan Corporation, plc. He counseled the neuroscience-based biotechnology company in connection with a $1.5 billion transaction that included the disposition of Élan’s Alzheimer’s Immunotherapy Program to an affiliate of Johnson & Johnson. He also advised Élan in the $1 billion sale of its drug formulation and manufacturing business, Élan Drug Technologies, which was combined with Alkermes Inc. under a newly-formed, Irish-based company, Alkermes plc. Cox has also worked extensively in life sciences-based transactions involving strategic alliances and research, development and commercialization collaborations, and is a recognized leader in intellectual property and royalty monetizations. Cox has counseled Cowen Healthcare Royalty Partners in a number of financing transactions involving the monetization of passive royalties, the creation of Synthetic Royalties® and the purchase of structured debt and equity securities.
“I am excited to join Cadwalader. The Firm has a tremendous platform with market-leading transactional capabilities and expertise in a wide range of industries. I look forward to working with Cadwalader’s extraordinarily talented attorneys in making the Firm the first choice for companies when confronting major strategic decisions,” Cox said.
Cox has been recognized for his work in Mergers, Acquisitions & Buyouts by the Legal 500.
“Chris is a talented and resourceful lawyer who can handle the most challenging and complex transactions,” said Lou Bevilacqua, Co-Chairman of the Corporate Department. “I look forward to working with him as we build our capacity to serve our clients.”
Cox received both his undergraduate degree and J.D. from University of Missouri where he was a member of the Missouri Law Review.
The Bank of England has initiated a review of its own exposure to LIBOR,
Scott Cammarn, Jonathan Watkins, Mark Chorazak, Aaron Lang
On 7 June 2019, Regulation (EU) 2019/876 (CRR II) was published in the Official Journal of the EU.